Anticoagulants in Coronary Disease

Overview

Journal Br Med J

Specialty General Medicine

Date 1954 Sep 25

PMID 13190239

Citations 2

Authors

A R Gilchrist

J A TULLOCH

Affiliations

Soon will be listed here.

Citing Articles

Haemorrhage during phenindione therapy.

MICKERSON J Br Med J. 1958; 1(5086):1522-3.

PMID: 13546611 PMC: 2029570. DOI: 10.1136/bmj.1.5086.1522.

Anticoagulant therapy in cardiac infarction.

MANSON D, Fullerton H Br Med J. 1956; 1(4957):6-8.

PMID: 13269936 PMC: 1978638. DOI: 10.1136/bmj.1.4957.6.

References

Jewell P, PILKINGTON T, Robinson B . Heparin and ethyl biscoum-acetate in prevention of experimental venous thrombosis. Br Med J. 1954; 1(4869):1013-6. PMC: 2084984. DOI: 10.1136/bmj.1.4869.1013. View

Wright H, KUBIK M, HYDEN M . Influence of anticoagulant administration on the rate of recanalization of experimentally thrombosed veins. Br J Surg. 1952; 40(160):163-6. DOI: 10.1002/bjs.18004016016. View

TULLOCH J, Gilchrist A . Anticoagulants in treatment of coronary thrombosis. Br Med J. 1950; 2(4686):965-71. PMC: 2039104. DOI: 10.1136/bmj.2.4686.965. View

Evans J, WOOD O, BREW E . Increased urinary urobilinogen following acute myocardial infarction. Circulation. 1952; 6(6):925-9. DOI: 10.1161/01.cir.6.6.925. View

Gilchrist A . Coronary thrombosis and its response to treatment. Br Med J. 1952; 2(4780):351-6. PMC: 2021053. DOI: 10.1136/bmj.2.4780.351. View

SCHILLING F . Anticoagulants in myocardial infarction. J Am Med Assoc. 1950; 143(9):785-9. DOI: 10.1001/jama.1950.02910440003002. View

OGURA J, FETTER N, BLANKENHORN M, Glueck H . CHANGES IN BLOOD COAGULATION FOLLOWING CORONARY THROMBOSIS MEASURED BY THE HEPARIN RETARDED CLOTTING TEST (WAUGH AND RUDDICK TEST). J Clin Invest. 1946; 25(4):586-96. PMC: 435597. DOI: 10.1172/JCI101741. View

LOUDON I, PEASE J, Cooke A . Anticoagulants in myocardial infarction. Br Med J. 1953; 1(4816):911-3. PMC: 2016374. DOI: 10.1136/bmj.1.4816.911. View

RUSSEK H, ZOHMAN B . An evaluation of anticoagulant therapy in the treatment of acute myocardial infarction. Am Heart J. 1952; 43(6):871-80. DOI: 10.1016/0002-8703(52)90242-1. View

10.

Evans W . Anticoagulant therapy in coronary occlusion. Proc R Soc Med. 1954; 47(5):318-23. PMC: 1918852. View

11.

Beaumont J, Chevalier H, LENEGRE J . Studies on spontaneous variations in blood coagulability immediately following myocardial infarction. Am Heart J. 1953; 45(5):756-68. DOI: 10.1016/0002-8703(53)90317-2. View

12.

Miller R, Jordan R, PARKER R, Edwards J . Thrombo-embolism in acute and in healed myocardial infarction. II. Systemic and pulmonary arterial occlusion. Circulation. 1952; 6(1):7-15. DOI: 10.1161/01.cir.6.1.7. View

13.

NICHOL E, BORG J . Long-term dicumarol therapy to prevent recurrent coronary artery thrombosis. Circulation. 1950; 1(5):1097-1104. DOI: 10.1161/01.cir.1.5.1097. View

14.

Toohey M . Vitamin K in anticoagulant therapy. Br Med J. 1954; 1(4869):1020-2. PMC: 2084963. DOI: 10.1136/bmj.1.4869.1020. View

15.

Douglas A, Brown A . Effect of vitamin K preparations on hypoprothrombinaemia induced by dicoumarol and tromexan. Br Med J. 1952; 1(4755):412-5. PMC: 2022702. DOI: 10.1136/bmj.1.4755.412. View

16.

RASHKOFF I, SCHAEFER L, MAGIDA M, Levy H . Evaluation of dicumarol therapy in 287 cases of acute myocardial infarction. J Mt Sinai Hosp N Y. 1952; 18(6):350-7. View

17.

Horn H, FIELD L, Dack S, MASTER A . Acute coronary insufficiency: pathological and physiological aspects; an analysis of twenty-five cases of subendocardial necrosis. Am Heart J. 1950; 40(1):63-80. DOI: 10.1016/0002-8703(50)90150-5. View